+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Travel Risk Management Services - Global Strategic Business Report

  • PDF Icon

    Report

  • 383 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6094072
The global market for Travel Risk Management Services was valued at US$114.8 Billion in 2025 and is projected to reach US$192.6 Billion by 2032, growing at a CAGR of 7.7% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global 'Travel Risk Management Services' Market - Key Trends & Drivers Summarized

Why Are Organizations Prioritizing Travel Risk Management More Than Ever Before?

In an age defined by unpredictable global events - ranging from pandemics and political unrest to natural disasters and cybersecurity threats - the importance of travel risk management (TRM) services has surged exponentially. What was once a niche concern confined to high-risk regions has now become a critical operational requirement for businesses of all sizes engaging in domestic or international travel. Corporations are increasingly aware of their duty of care obligations to safeguard employees traveling for work, particularly in industries like consulting, energy, defense, and international aid. TRM services now go far beyond simple itinerary tracking or emergency contacts; they encompass real-time threat intelligence, traveler tracking, health advisory systems, evacuation protocols, and compliance with international safety regulations. The COVID-19 pandemic underscored the volatility of travel and reinforced the need for agile, tech-enabled TRM platforms that can instantly assess risk, initiate alerts, and provide secure channels for assistance. As global mobility returns to pre-pandemic levels - amid rising geopolitical complexity and environmental volatility - organizations are investing in comprehensive, customizable TRM strategies to mitigate liability, reduce disruption, and protect human capital across every stage of the journey.

How Are Digital Platforms Transforming the Scope of Travel Risk Services?

Technology is at the core of the next evolution in travel risk management services, enabling dynamic, data-driven approaches to traveler safety and resilience. Today’s TRM providers are leveraging AI and machine learning to analyze thousands of data sources in real time - from geopolitical developments and weather forecasts to cyber incidents and infectious disease outbreaks. These platforms provide predictive alerts, route-based threat mapping, and risk scoring tools that help both travelers and organizations make informed decisions. Geolocation technology is critical, allowing companies to track the whereabouts of their employees and assess exposure to emerging risks. Integration with travel booking tools and HR systems ensures a seamless experience from pre-trip approval to post-trip reporting. Mobile apps now serve as personal safety companions, offering emergency SOS features, virtual check-ins, health advisories, and secure communication channels. Cybersecurity is another growing frontier, as remote work on public networks during travel exposes individuals to digital threats - prompting TRM platforms to add features such as VPN support and phishing alert systems. The transition from reactive to proactive risk mitigation is enabled by this technology backbone, which empowers companies to adopt real-time, scalable solutions suited to diverse operating environments.

Which Sectors and Geographies Are Driving Demand for TRM Services?

The demand for travel risk management services is expanding across industries and geographies, driven by sector-specific exposure to operational risks and global compliance frameworks. The oil and gas sector, for instance, frequently sends personnel to politically unstable or geographically remote regions, necessitating enhanced security logistics, local intelligence, and evacuation readiness. NGOs and humanitarian organizations operating in conflict zones or disaster-affected areas similarly rely on advanced TRM programs to ensure the safety of staff in volatile conditions. Corporate sectors such as finance, law, and consulting - where international client meetings and conferences are routine - are increasingly embedding TRM policies into their global mobility programs. Healthcare and academic institutions with field research teams also represent a growing user base, especially when sending personnel to health-sensitive zones or regions with infrastructural challenges. Regionally, North America and Europe lead in TRM adoption, influenced by legal obligations surrounding duty of care and workforce safety. However, the Asia-Pacific region is catching up quickly, as outbound business travel from countries like China, India, and Singapore increases and regional players expand operations overseas. Additionally, Africa and the Middle East represent key markets where high-risk travel environments necessitate robust and adaptive risk management systems tailored to volatile security conditions and infrastructural limitations.

The Growth in the Travel Risk Management Services Market Is Driven by Several Factors

The growth of the travel risk management services market is fueled by a convergence of operational risks, regulatory requirements, and changing patterns in global mobility. One of the primary drivers is the heightened perception of threat across geopolitical, environmental, and health domains, compelling organizations to proactively safeguard travelers across all journey phases. The rising frequency of natural disasters, civil unrest, terrorism, and cyber threats has amplified the need for comprehensive, real-time intelligence and rapid-response capabilities. Another critical factor is the tightening of duty of care regulations globally, which hold employers legally accountable for the safety of their mobile workforce - especially in high-risk or international settings. The rapid digital transformation of corporate travel programs is also playing a role, enabling better integration of risk management services with HR platforms, booking tools, and communication systems for seamless implementation. Moreover, the shift toward hybrid and remote work models has blurred traditional travel boundaries, necessitating broader monitoring and risk assessments even for semi-permanent overseas placements. Traveler expectations are also influencing demand; professionals now prioritize safety assurances, emergency support, and real-time alerts as part of a comprehensive travel experience. Finally, industry-specific needs - from offshore deployments and humanitarian missions to academic fieldwork - are driving the customization of TRM solutions, solidifying their importance in a risk-laden global landscape.

Report Scope

The report analyzes the Travel Risk Management Services market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Service Type (Travel Security, Crisis Management, Data Security, Health Security, Assistance & Tracking, Other Service Types); Organization Size (Large Enterprises, Medium Enterprises, Small Enterprises); End-Use (Agri Food & Beverages, Pharmaceutical & Healthcare, Hospitality, Business Services & Consulting, IT Technology & Telecom, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Travel Security segment, which is expected to reach US$49.1 Billion by 2032 with a CAGR of a 9.6%. The Crisis Management segment is also set to grow at 5.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $31.3 Billion in 2025, and China, forecasted to grow at an impressive 12.0% CAGR to reach $42.5 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Travel Risk Management Services Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Travel Risk Management Services Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Travel Risk Management Services Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Anvil Group, AXA Partners, BCD Travel, CEGA Group, Chubb Limited and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Travel Risk Management Services market report include:

  • Anvil Group
  • AXA Partners
  • BCD Travel
  • CEGA Group
  • Chubb Limited
  • Collinson Group
  • Control Risks
  • Cover-More Group
  • Crisis24
  • CTM (Corporate Travel Management)
  • CWT (Carlson Wagonlit Travel)
  • Drum Cussac
  • Everbridge
  • FocusPoint International
  • Global Guardian
  • Global Rescue
  • Healix International
  • International SOS
  • On Call International
  • Riskline

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Travel Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising International Travel and Cross-Border Movement Drives Demand for Pre-Travel Vaccinations
  • Increased Awareness of Endemic Disease Risks in Emerging Destinations Fuels Preventive Vaccine Uptake
  • Growth in Business, Educational, and Medical Tourism Supports Volume Demand
  • Expanded Inclusion of Yellow Fever, Typhoid, Hepatitis, and Meningococcal Vaccines in Pre-Travel Protocols
  • Regulatory Requirements for Entry Into Certain Countries Drive Compliance-Driven Vaccine Demand
  • Use of Combination and Single-Dose Formulations Improves Convenience and Reduces Missed Doses
  • Growth in Private Clinics and Travel Health Centers Enhances Access to Targeted Immunizations
  • Increased Awareness Campaigns by Health Ministries and Airlines Support Preventive Measures
  • Seasonal Travel Peaks Correlate With Vaccine Appointment Upticks in Urban Markets
  • Availability of Pre-Filled Syringes and Multi-Dose Packs Improves Distribution Efficiency
  • Travel Health App Integrations Support Vaccine Reminders and Record Management
  • Adoption in Backpacking, Volunteer, and High-Risk Travel Segments Sustains Niche Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Travel Vaccines Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Travel Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Travel Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Travel Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Influenza Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Influenza Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Influenza Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Diphtheria Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Diphtheria Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Diphtheria Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Hepatitis Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Hepatitis Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Hepatitis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Typhoid & Other Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Typhoid & Other Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Typhoid & Other Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Adult End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Adult End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Adult End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Pediatric End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Pediatric End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Pediatric End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 24: USA Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: USA 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 26: USA Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 27: USA Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: USA 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 30: Canada Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: Canada 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 32: Canada Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 33: Canada Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: Canada 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
JAPAN
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 36: Japan Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: Japan 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 38: Japan Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 39: Japan Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: Japan 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
CHINA
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 42: China Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 43: China 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 44: China Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 45: China Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 46: China 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
EUROPE
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Travel Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 48: Europe Historic Review for Travel Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 49: Europe 13-Year Perspective for Travel Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 50: Europe Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 51: Europe Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 52: Europe 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 53: Europe Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 54: Europe Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 55: Europe 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
FRANCE
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 57: France Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 58: France 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 59: France Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 60: France Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 61: France 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
GERMANY
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 63: Germany Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 64: Germany 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 65: Germany Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 66: Germany Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 67: Germany 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 69: Italy Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 70: Italy 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 71: Italy Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 72: Italy Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 73: Italy 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 75: UK Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 76: UK 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 77: UK Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 78: UK Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 79: UK 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 81: Spain Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 82: Spain 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 83: Spain Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 84: Spain Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 85: Spain 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 87: Russia Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 88: Russia 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 89: Russia Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 90: Russia Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 91: Russia 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 93: Rest of Europe Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 94: Rest of Europe 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 96: Rest of Europe Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 97: Rest of Europe 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
ASIA-PACIFIC
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Travel Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Travel Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 100: Asia-Pacific 13-Year Perspective for Travel Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Travel Vaccines by Disease Type - Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 103: Asia-Pacific 13-Year Perspective for Travel Vaccines by Disease Type - Percentage Breakdown of Value Sales for Influenza Vaccines, Diphtheria Vaccines, Hepatitis Vaccines and Typhoid & Other Vaccines for the Years 2020, 2026 & 2032
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Travel Vaccines by End-Use - Adult End-Use and Pediatric End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 106: Asia-Pacific 13-Year Perspective for Travel Vaccines by End-Use - Percentage Breakdown of Value Sales for Adult End-Use and Pediatric End-Use for the Years 2020, 2026 & 2032
AUSTRALIA
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Travel Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Anvil Group
  • AXA Partners
  • BCD Travel
  • CEGA Group
  • Chubb Limited
  • Collinson Group
  • Control Risks
  • Cover-More Group
  • Crisis24
  • CTM (Corporate Travel Management)
  • CWT (Carlson Wagonlit Travel)
  • Drum Cussac
  • Everbridge
  • FocusPoint International
  • Global Guardian
  • Global Rescue
  • Healix International
  • International SOS
  • On Call International
  • Riskline

Table Information